Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 298.50
+3.40 (1.15%)
Jun 18, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 725.21 million as of June 18, 2025. Its market cap has increased by 3.42% in one year.
Market Cap
725.21M
Enterprise Value
561.98M
Revenue
35.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
298.50
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 725.21M, an increase of 1,366.56%. That is a compound annual growth rate of 8.44%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 70.16B |
| Danel (Adir Yeoshua) | 2.49B |
| Kamada | 1.42B |
| Bait Bakfar | 1.08B |
| BrainsWay | 730.85M |
| Novolog (Pharm-Up 1966) | 721.82M |
| SofWave Medical | 707.81M |
| Ilex Medical | 670.84M |